Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)
Clinical trial NCT04741165 · UNKNOWN
Trial details
- NCT number
- NCT04741165
- Sponsor
- Taizhou Hanzhong biomedical co. LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-07
- Primary completion
- 2022-04-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.